![](https://endpts.com/wp-content/uploads/2023/09/Gaurav-Shah.jpg)
Gaurav Shah, Rocket Pharma CEO
Rocket Pharmaceuticals says FDA agrees to 12-patient study for accelerated approval, expects to raise $175M
Rocket Pharmaceuticals announced Wednesday that it expects to raise $175 million from a stock sale, a day after …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.